Effect of rapamycin on the inhibitory effects of imatinib mesylate and IFNα on leukemic CFU-GM progenitors
. | . | % control colony formation . | . | . | . | . | ||||
---|---|---|---|---|---|---|---|---|---|---|
Case . | Source . | Rapamycin . | IFNα . | IFNα + rapamycin . | imatinib mesylate . | imatinib mesylate + rapamycin . | ||||
1 | PB | 31 | — | — | 19 | 8 | ||||
2* | PB | 30 ± 3 | 39 ± 4 | 19 ± 4 | 22 ± 6 | 5 ± 2 | ||||
3 | PB | 48 | 53 | 23 | 23 | 14 | ||||
4* | BM | 26 ± 4.5 | 54 ± 8 | 15 ± 2 | — | — | ||||
5 | BM | 75 | — | — | 16 | 1.5 | ||||
6 | PB | 34 | 70 | 13 | — | — |
. | . | % control colony formation . | . | . | . | . | ||||
---|---|---|---|---|---|---|---|---|---|---|
Case . | Source . | Rapamycin . | IFNα . | IFNα + rapamycin . | imatinib mesylate . | imatinib mesylate + rapamycin . | ||||
1 | PB | 31 | — | — | 19 | 8 | ||||
2* | PB | 30 ± 3 | 39 ± 4 | 19 ± 4 | 22 ± 6 | 5 ± 2 | ||||
3 | PB | 48 | 53 | 23 | 23 | 14 | ||||
4* | BM | 26 ± 4.5 | 54 ± 8 | 15 ± 2 | — | — | ||||
5 | BM | 75 | — | — | 16 | 1.5 | ||||
6 | PB | 34 | 70 | 13 | — | — |
PB indicates peripheral blood;—, not done; and BM, bone marrow.
For cases 2 and 4, values shown are means ± SE of 2 independent experiments.